| |
|
September 14th, 2009:
OctoPlus signs service contract with Axentis Pharma
|
|
|
July 16th, 2009:
B. Cepacia - Liposomal tobramycin receives second orphan drug designation from US FDA within weeks
|
|
|
April 30th, 2009:
Cystic Fibrosis – Orphan drug designation for innovative treatment against lung infections by Axentis Pharma
|
|
|
February 2nd, 2009:
Chronic Lung Disease – Axentis Pharma attracts investment interest
|
|
|
June 26th, 2008:
Cystic Fibrosis - Axentis Pharma takes over patents and continues development of innovative platform technology
|
|
|
December 19th, 2007:
Cystic Fibrosis - License agreement boosts development of therapy against lung infections
|
|
|
|
